Verena Gartner

Learn More
PURPOSE The relevance of a family history for venous thromboembolism with regard to the likelihood for recurrence is unknown. SUBJECTS AND METHODS We studied 826 patients for an average of 36 months after a first unprovoked venous thromboembolism and withdrawal of oral anticoagulation. Patients with cancer, lupus anticoagulant, or deficiency of(More)
Patients with first venous thromboembolism (VTE) and high factor VIII (FVIII) are at increased risk of recurrence. It is unknown whether these patients benefit from prolonged secondary thrombophrophylaxis. In a prospective trial patients with first spontaneous VTE and FVIII levels >230 IU/dl were randomized to discontinue vitamin K Antagonist (VKA) after 6(More)
BACKGROUND Microparticles (MPs) have procoagulant properties as shown in vitro and in animal models. Their role in haemostatic system activation at the site of a vascular injury in vivo in humans has not been studied. MATERIAL AND METHODS In a prospective randomized crossover study, 13 healthy volunteers were given 100 mg acetylsalicylic acid or placebo(More)
BACKGROUND Oral contraceptives increase the thrombotic risk in women with factor V Leiden. Emotional aspects of genetic testing prior to the prescription of oral contraceptives (OC), aspects of counseling and referral patterns are widely unknown. STUDY DESIGN Two hundred forty-seven women with and 132 women without factor V Leiden were interviewed by(More)
  • 1